Steve E. Krognes insider trades

Open-market stock purchases and sales by Steve E. Krognes, Director at Guardant Health, Inc, from SEC Form 4 filings since Mar 22, 2016.

Recent trades

DateStockTradeValue
Sep 16, 2026GH Guardant Health, IncSold$192K
Sep 16, 2026GH Guardant Health, IncSold$579K
Sep 16, 2026GH Guardant Health, IncSold$229K
Sep 16, 2026GH Guardant Health, IncSold$172K
Jun 30, 2026GH Guardant Health, IncBought (not open market)—
Jun 30, 2026GH Guardant Health, IncBought (not open market)—
Jun 17, 2026GH Guardant Health, IncBought (not open market)—
Jun 17, 2026GH Guardant Health, IncBought (not open market)—
Jun 11, 2026PLRX Pliant Therapeutics, IncBought (not open market)—
Jun 4, 2026GH Guardant Health, IncSold$1.2M
Jun 3, 2026DNLI Denali Therapeutics IncBought (not open market)—
Jun 3, 2026DNLI Denali Therapeutics IncBought (not open market)—
May 31, 2026GH Guardant Health, IncBought (not open market)—
Apr 30, 2026GH Guardant Health, IncBought (not open market)—
Mar 31, 2026GH Guardant Health, IncBought (not open market)—
Feb 28, 2026GH Guardant Health, IncBought (not open market)—
Jan 31, 2026GH Guardant Health, IncBought (not open market)—
Dec 31, 2025GH Guardant Health, IncBought (not open market)—
Nov 30, 2025GH Guardant Health, IncBought (not open market)—
Oct 31, 2025GH Guardant Health, IncBought (not open market)—

Companies traded

  • GH Guardant Health, Inc: 5 sales, last Sep 16, 2026
  • PLRX Pliant Therapeutics, Inc: other filings, last Jun 11, 2026
  • DNLI Denali Therapeutics Inc: 37 sales, last Jun 3, 2026
  • GRTS Gritstone bio, Inc: other filings, last Jun 16, 2023
  • CRVS Corvus Pharmaceuticals, Inc: other filings, last Jun 9, 2020

Get free alerts when Steve E. Krognes files a new trade →